Rates of some, but not all, cancers are higher in people living with HIV than HIV-negative people. This is often because of the effects of HIV on the immune system.
With oncologist at the Barts Cancer Institute, Dr Jessica Okosun, and community sexual and reproductive health registrar and author of Divided, Dr Annabel Sowemimo.
At CROI 2022, Professor Joel Palefsky from the University of California San Francisco talks about the ANCHOR trial, which has showed that screening and early treatment reduces anal cancer in people with HIV.
